Last updated on June 2018

Study of Motilitone to Treat Functional Dyspepsia

Brief description of study

This study is to evaluate efficacy of the investigational drug Motilitone at 90 mg in patients with Functional Dyspepsia as measured by change in maximum tolerated volume and aggregate symptom score on the nutrient drink test.

Clinical Study Identifier: NCT02365701

Contact Investigators or Research Sites near you

Start Over

Madhusudan Grover, MBBS

Mayo Clinic
Rochester, MN United States